Status:
RECRUITING
Virtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients
Lead Sponsor:
University of Michigan
Conditions:
Inflammatory Bowel Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The research is studying virtual reality (VR)-directed brain-gut behavioral therapy (BGBT) as a pain treatment option for hospitalized patients with inflammatory bowel disease (IBD). This study is bei...
Eligibility Criteria
Inclusion
- Patients with Inflammatory Bowel Disease and self-reported pain
- Hospitalized for management of IBD (inpatient medicine services at Michigan Medicine)
Exclusion
- Patients that do not report pain
- Anticipated length of hospital stay is less than 72 hours
- Patients that have previously had a seizure, loss of awareness, or other symptoms linked to an epileptic condition
- Patients with binocular vision loss
- Patients with an uncontrolled cardiac condition such as an arrhythmia, coronary artery disease, or neurological/cerebrovascular disease.
- Patients that are currently pregnant
Key Trial Info
Start Date :
February 13 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06188793
Start Date
February 13 2024
End Date
February 1 2026
Last Update
February 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48109